Press Room

        
      View     

    News / May 11, 2017  

    Bioconnect Seminar at the Hovione Cork Site  
    The Hovione site welcomed close to 50 people from the Irish Pharma, Biotech and University sectors for a combined seminar with Bioconnect Ireland on the theme of Tech Transfer in the pharmaceutical industry.  

      View     

    Article / Apr 01, 2017  

    Integrated Design Space to Develop Better DPI Formulations  
    ONdrugDelivery, April, 2017  

      View     

    Article / Apr 01, 2017  

    PAT for Continuous API Manufacturing Progresses  
    Advances in process analytical technology have been achieved, but significant challenges remain  

      View     

    News / Mar 27, 2017  

    Hovione Japan: New Website  

      View     

    Press Clipping / Mar 24, 2017  

    Hovione Cork: A unique combination of capacity and high quality people  
    Irish Examiner, Pharma Supplement, 24 Mar 2017  

      View     

    News / Mar 22, 2017  

    2017 CMO Leadership Award  
    Hovione recognized in the 2017 CMO Leardership Awards  

      View     

    Article / Mar 17, 2017  

    Hovione establishes presence in Osaka  
    JETRO, March 17, 2017  

      View     

    Article / Mar 08, 2017  

    Expanding the Commercial Options  
    Pharma's Almanac, Q1 2017, Mar 8, 2017  

      View     

    Article / Mar 07, 2017  

    Know Your Drug: A Solution to Dissolution  
    ContractPharma, March 7, 2017  

      View     

    News / Dec 22, 2016  

    Season's Greetings  
    Season's Greetings from Hovione

‹ previous
…
4
5
6
7
8
9
…
next ›

Contact Us

If you would like to learn more about Hovione, kindly fill in the form below and we will be revert to you soon.

We’d welcome your feedback!

Thank you for visiting our website.

Would you like to take a few minutes to complete our short survey to let us know how we can improve your experience?

No, thanks Yes, please

This website uses cookies to give you the best, most relevant experience. By continuing to browse the website, you are agreeing to our use of cookies. Learn More.